助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[849]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
未完全匹配句对
    Tumors of the Trachea and Major Bronchi and X-ray Diagnosis
    气管和主支气管肿瘤与X线诊断
    Clinical Application of Pectoralis Major Myocataneous Flap in the Combined Treatment of Advanced Oropharyngeal Cancer
    胸大肌皮瓣在晚期口咽癌综合治疗中的应用
    COMBINED SURGERY AND RADIOTHERAPY OF 105 CASES OF MAJOR SALIVERY GLAND CARCINOMA
    105例大涎腺恶性肿瘤疗效分析
    Clinical Analysis of 34 Cases of Carcinoma of the Esophagus and the Lungs Treated with Combined Chemotherapy of Major Content Carboplatin
    卡铂为主联合化疗治疗食管癌、肺癌34例临床分析
    Reconstruction with Pedicled Musculocutaneous Flap Using Pectoralis Major Muscle in 21 Cases of Tumor of Head and Nock
    胸大肌肌皮瓣修复头颈部肿瘤术后缺损21例总结
    Application of Pectoralis Major Myocutaneous Flap to Cancer Surgery of Head and Neck
    胸大肌肌皮瓣在咽喉、头颈外科晚期癌的应用
    Major Complications and Survival Quality of Afterloading Intracavitary Radiation of High-Dose Rate for Carcinoma of the Uterine Cervix
    高剂量率后装腔内放射治疗宫颈癌的主要并发症及生存质量
    RETINOIC ACID NUCLEAR RECEPTORα (RARα),A MAJOR ROLE IN MEDIATING RETINOIDS INHIBITION OF GROWTH IN HUMAN BREAST CARCINOMA CELLS
    RETINOIC ACID NUCLEAR RECEPTORα (RARα),A MAJORROLE IN MEDIATING RETINOIDS INHIBITION OF GROWTH IN HU
    THE APPLICATION OF PECTORALIS MAJOR MYOCUTANEUS FLAP IN CANCER OF HYPOPHARYNX OF LATE-STAGE BY OPERATED
    带蒂胸大肌岛状肌皮瓣在晚期下咽癌手术中的应用
    The results demonstrate that 3H-IN has good affinity to the tumor tissue and the major part accumulated in tumor is not the IN prototype.
    结果提示,3H-IN有很好的瘤组织趋向性,其药物原形并非在肿瘤中蓄积的主要成分。
    Major items were observed including objective response rate(ORR=CR+PR),clinical benefit rate(CBR=CR+PR+SD≥24 weeks),time to progress(TTP),time to failure(TTF),safety and toxicity.
    主要观察指标为:客观反应率(ORR=CR+PR,其中CR为完全缓解,PR为部分缓解)、临床获益率(CBR=CR+PR+SD≥24周,其中SD为疾病稳定)、肿瘤进展时间(TTP),肿瘤治疗失败时间(TTF)、安全性和毒副反应。
    The major toxicity reaction were peripheral neurotoxicity(69.57%),myelosuppression(30.43%), nausea/vomiting(39.13%).
    主要不良反应有外周神经系统病变,骨髓抑制,恶心呕吐,发生率分别为69.57%,30.43%,39.13%。
    Results The total response rate in FP group was 35.48%,The total response rate in FOLFOX4 group was 40.00%. Major toxic effects of FP group was gastrointestinal tract reaction.
    结果FP组总有效率35.48%,主要不良反应为消化道毒性,FOLFOX4组总有效率40.00%,主要不良反应为神经毒性。
    The major toxicity noted was myelotoxisity. The rate of grade Ⅲ,Ⅳ of neutropenia is 21.1%, thrombocytopenia is 3.3 % and anemia is 10.0%.
    主要不良反应为骨髓抑制,其中白细胞下降Ⅲ,Ⅳ度为21.1%,血红蛋白下降Ⅲ,Ⅳ度为10.0%,血小板下降Ⅲ度为3.3%,未发现Ⅳ度反应。
    Results:No case in the first group and 26 cases(76.5%) in the second group suffered from postoperative atrophy of pectoralis major muscles(P<0.01).
    结果:保留胸前神经组无重度胸大肌萎缩,不保留胸前神经组重度萎缩26例(76.5%)。 经统计学检验,保留胸前神经组重度胸大肌萎缩情况较不保留胸前神经组明显减少(P<0.01)。
    Multidrug resistance(MDR) against anticancer drugs is one of the major problems in terms of chemotherapy failure.
    恶性肿瘤的多药耐药(multidrug resistance,MDR)是恶性肿瘤化疗失败的主要原因。
    The major toxicities were bone marrow suppression (52.1%) and reactions relative to digestive system (35.2%). All of complications were RTOGⅠ/Ⅱ degree.
    毒副反应主要为血液学毒性(52.1%)及消化道反应(35.2%),且均仅为Ⅰ/Ⅱ度。
    Patients of stage III to IV and grade 3 were 45.45% and 54.55% in UPSC group,compared with 29.73% and 27.57% in UEC group(P<0.05). Surgery was the major way to deal with UPSC patients.
    UPSC组和UEC组III~IV期患者分别占45.45%和29.73%,G3级患者分别占54.55%和27.57%,UPSC组无论是在临床分期或病理分级上均较UEC组晚(P<0.05)。
    The major cytotoxicity was leukopenia in the TP group and thrombocytopenia in the GP group.
    GP组不良反应以血小板降低为主,TP组以白细胞降低为主,均可耐受。
    The S100 immunohistochemical and cell shape counting results showed schwann cells were the major cells of neurofibromas in both NF1 group and non-NF1 group.
    S100多克隆抗体标记及细胞形态计数显示两组瘤组织主要由雪旺细胞而不是成纤维细胞组成。
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社